Story not found
This article may have been removed or the link is incorrect.
← Return to briefing
local
New pill nearly doubles survival time for pancreatic cancer patients
By KHOU Houston
·
· 1 min read
Researchers say the pill, daraxonrasib, works by blocking a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases.
Continue reading
This preview is provided by The Woodlands News. Full article available at .